Cargando…

Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?

Many patients with coronavirus disease 2019 (COVID-19) have a hyperactive immune response (cytokine storm) which has been incriminated in multiorgan dysfunction (MOD). Interleukin-6 (IL-6) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are the key cytokines involved in mediating syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mughal, Mohsin S, Kaur, Ikwinder, Kakadia, Mili, Wang, Chang, Alhashemi, Reem, Salloum, Rafah, Ricca, Anthony, Granet, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815303/ https://www.ncbi.nlm.nih.gov/pubmed/33489621 http://dx.doi.org/10.7759/cureus.12214

Ejemplares similares

RESPIRATORY RATE – OXYGENATION (ROX) INDEX CORRELATION WITH HIGH-FLOW NASAL CANNULA OUTCOME IN COVID-19 RESPIRATORY FAILURE: A SINGLE CENTER EXPERIENCE
por: KRAMER, VIOLET E., et al.
Publicado: (2022)

Su326 IS TRANSAMINITIS AN INDEPENDENT RISK FACTOR FOR ALL-CAUSE MORTALITY IN COVID-19?
por: Mughal, Mohsin, et al.
Publicado: (2021)

Acute viral myositis complicated by rhabdomyolysis: a sole manifestation of COVID-19 infection
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2021)

The Potential Role of Therapeutic Dose of Low Molecular Weight Heparin (LWMH) to Attenuate Hyper-Inflammatory State in Hospitalized COVID-19 Patients
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2020)

CAN INFLAMMATORY MARKERS PREDICT THE SUCCESSFUL EXTUBATION IN PATIENTS WITH COVID-19?
por: Mughal, Mohsin, et al.
Publicado: (2020)

The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications—a single-center, prospective, pilot study
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2020)

692. Secondary Infections and Coinfections in Coronavirus Disease 2019 (COVID-19)
por: Kaur, Ikwinder P, et al.
Publicado: (2020)

Cerebral Venous Sinus Thrombosis in COVID-19: An Unusual Presentation
por: Kaur, Ikwinder, et al.
Publicado: (2021)

Sjogren's Syndrome and Clinical Benefits of Low-Dose Naltrexone Therapy: Additional Case Reports
por: Zashin, Scott
Publicado: (2020)

Hard Palate Perforation in an Elderly Man With Dementia
por: Mughal, Mohsin S, et al.
Publicado: (2021)

COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2020)

Pantoea agglomerans Bacteremia: Is It Dangerous?
por: Kaur, Ikwinder Preet, et al.
Publicado: (2020)

Early Initiation of Tocilizumab in Clinically Isolated Aortitis
por: Huang, Irvin J, et al.
Publicado: (2019)

The Use of Single Therapy With Tocilizumab Versus Combination Therapy With Remdesivir and Tocilizumab in SARS-CoV-2 Patients in El Paso, Texas
por: Almaghlouth, Nouf K, et al.
Publicado: (2021)

Use of Tocilizumab May Avoid the Need of Invasive Ventilation
por: Adhikari, Anurag, et al.
Publicado: (2021)

The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

A Review of Left Ventricular Non-compaction Cardiomyopathy (LVNC)
por: Mirza, Hasan, et al.
Publicado: (2022)

Organizing Pneumonia Induced by Tocilizumab in a Patient with Rheumatoid Arthritis
por: Gouveia, Pedro A, et al.
Publicado: (2020)

Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy
por: Zashin, Scott
Publicado: (2019)

Tocilizumab and Thromboembolism in COVID-19: A Retrospective Hospital-Based Cohort Analysis
por: Chan, Kok Hoe, et al.
Publicado: (2021)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Readmissions on Teaching Versus Non-Teaching Services: Are They Any Different?
por: Shaw, Jawaid A, et al.
Publicado: (2020)

Are There Any Ethnic Differences in the Response to Baricitinib for the Treatment of Rheumatoid Arthritis?
por: Zahir Hussain, Wajith Hussain, et al.
Publicado: (2021)

Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence
por: Kotak, Sohny, et al.
Publicado: (2020)

The Role of Additional Epididymis Resection during Hydrocelectomy: Is It of Any Benefit in Comparison to Simple Hydrocelectomy?
por: Grossmann, Nico C., et al.
Publicado: (2023)

E-cigarette or vaping product use associated lung injury, (EVALI) - A diagnosis of exclusion
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2020)

Posterior Reversible Encephalopathy Syndrome in a Patient With SARS-CoV-2 Infection Treated With Tocilizumab
por: Talluri, Krishna, et al.
Publicado: (2021)

Tocilizumab for COVID-19 Acute Respiratory Distress Syndrome: Outcomes Assessment Using the WHO Ordinal Scale
por: Nasir, Nosheen, et al.
Publicado: (2020)

Do patients receive any benefit from the addition of perioperative immunotherapy-chemotherapy for solid tumors?
por: Quan, Rencui, et al.
Publicado: (2023)

Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease
por: Gurala, Dhineshreddy, et al.
Publicado: (2020)

Are There Any Cardioprotective Effects or Safety Concerns of Erythropoietin in Patients With Myocardial Infarction? A Systematic Review
por: Jean-Baptiste, Wilford, et al.
Publicado: (2022)

Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study
por: Al-Qaaneh, Ayman M., et al.
Publicado: (2022)

A Case Report on Adult-Onset Still’s Disease Successfully Treated With Tocilizumab: A Brief Review on its Safety and Efficacy
por: Nagalli, Shivaraj, et al.
Publicado: (2020)

Fourth dose of COVID-19 vaccine: Does it still contribute any additional immunoprotection?
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Predictors of Mortality Amongst Tocilizumab Administered COVID-19 Asian Indians: A Predictive Study From a Tertiary Care Centre
por: Desai, Hardik D, et al.
Publicado: (2021)

Severe COVID-19 Pneumonia Treated by Intensive Immune Suppression Therapy With a Combination of Steroid Pulse and Tocilizumab Followed by a Tapering Dose of Steroid Therapy During the Delta (B.1.617.2) Variant Outbreak: A Successfully Treated Case
por: Muramatsu, Ken-ichi, et al.
Publicado: (2021)

Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
por: Negoescu, Andra F., et al.
Publicado: (2014)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Yang, Chengliang, et al.
Publicado: (2021)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Neumann, Avidan U, et al.
Publicado: (2021)

Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone
por: Belhassen-García, Moncef, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h92fovsim1u4rb7qibjsq3jr59